Thus, GDF15 may have potential clinical implications for the treatment of hereditary obesity, especially in the circumstance of leptin receptor deficiency, which cannot be improved by leptin administration. This evidence concerns the gene LEP and hyperinsulinemic hypoglycemia, familial, 4.